BEIJING, June 26 (Xinhua) -- Hainan Honz Pharmaceutical Co., Ltd (300086.SZ) announced on Tuesday that it had received a paper of letters patent called COMPONENT AND METHOD FOR TREATING VIRAL DISEASE from the United States Patent and Trademark Office (USPTO).
This patent aims to produce a kind of composition for treating viral infectious diseases.
According to the company filing, the acquisition of the patent will help to further enhance the company's core competitiveness, cast a positive impact on the company's future production and operation, and further exert the advantages of the company's independent intellectual property rights. (Edited by Ma Xin, maxin11@xinhua.org)